| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 04/30/2003 | CN1414095A Preparation method of high actirity earthworm kinase dry powder |
| 04/30/2003 | CN1414094A Using yeast secretion to express ruitipu enzyme |
| 04/30/2003 | CN1107114C High-temp. non-inactivation preparation method of superoxide dismutase |
| 04/30/2003 | CN1106870C Biodegradation of metal cyanides |
| 04/30/2003 | CA2409536A1 Self-sustaining fermentation medium preparation process |
| 04/29/2003 | US6555734 Modified dihydroflavonol 4-reductase (DFR) nucleic acids;encoding the modified DFR characterized by its ability to reduce dihydrokaempferol preferentially and increase the content of pelargonidin-based pigments |
| 04/29/2003 | US6555733 Genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use |
| 04/29/2003 | US6555714 P-hydrophenylpyruvate dioxygenases (HPPD) from plants is incubated with test substrate and enzymatic activity of enzyme is determined in comparison with activity of uninhibited enzyme |
| 04/29/2003 | US6555673 Synthetic promoters |
| 04/29/2003 | US6555669 Nucleotide sequences coding preferential oligopeptide for use in human therapeutics and diagnostics; for use in the treatment of cancer and Parkinson's Disease |
| 04/29/2003 | US6555668 Comprising a non-nucleotide in a single-stranded region; hammerhead ribozyme having a non-nucleotide in the catalytic core; synthesis of abasic ribonucleoside mimetics |
| 04/29/2003 | US6555657 Isolated transcription factor for an alpha-amylase promoter in filamentous fungi |
| 04/29/2003 | US6555371 Enzyme which synthesizes ganglioside by transferring sialic acid to a galactose residue of lactosylceramide |
| 04/29/2003 | US6555370 Bifunctional selectable fusion genes |
| 04/29/2003 | US6555369 Inducing nucleotide sequence biosynthesis in cells of nervous system; obtain vector coding preferential genes, transfect cells of nervous system, monitor cell for preferential expression |
| 04/29/2003 | US6555358 Chemotherapeutic target for antiprotozoal agents |
| 04/29/2003 | US6555357 Structure-specific nucleases derived from thermostable organisms, used to cleave target-dependent cleavage structures |
| 04/29/2003 | US6555356 Methods for microbial regulation |
| 04/29/2003 | US6555355 Mutating the genes for a number of subtilases and expressing the in suitable hosts |
| 04/29/2003 | US6555354 Enzymatic polypeptide for use in the treatment of inflammation, reperfusion injury, viral diseases, allergies, infections, pain, autoimmune,cardiovascular, nervous system, kidney, urogenital, sexual, kidney disorders |
| 04/29/2003 | US6555353 Methanotrophic carbon metabolism pathway genes and enzymes |
| 04/29/2003 | US6555352 Peptide for use in human therapeutics and diagnostic compositions |
| 04/29/2003 | US6555351 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 04/29/2003 | US6555349 Methods for amplifying and sequencing nucleic acid molecules using a three component polymerase |
| 04/29/2003 | US6555348 Enzyme isolated from a Bifidobacterium |
| 04/29/2003 | US6555338 Given nucleotide sequence; use of polynucleotides and polypeptides in diagnostic assays, and possibly functional genomics |
| 04/29/2003 | US6555335 Xylanase from Trichoderma reesei , method for production thereof, and methods employing this enzyme |
| 04/29/2003 | US6555329 Detecting a modulator of chromosomal stability during meiosis amd mitosis; obtain cell sample, incubate with modulator and substrate, monitor cell for adjustment in cell division |
| 04/29/2003 | US6555315 Capturing genes potentially encoding novel biochemical pathways of interest in prokaryotic systems, and screening for these pathways using high throughput screening assays |
| 04/29/2003 | US6555311 Hepatitis B variants exhibiting complete or partial resistance to nucleoside analogues and/or reduced interactivity with antibodies to viral surface components; use determining if a strain will be antiviral drug resistant |
| 04/29/2003 | US6555155 Adding predetermined quantity of krill hydrolysate to liquid marine protein and dry carrier to produce mixture, co-drying mixture to obtain end product |
| 04/29/2003 | US6555116 Hypo-allergenic pollen protein that has been treated with thioredoxin, nicotinamide adenine dinucleotide phosphate-thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH). |
| 04/29/2003 | CA2281206C Geranyl diphosphate synthase genes |
| 04/29/2003 | CA2121369C Inhibitors of dipeptidyl-aminopeptidase type iv |
| 04/24/2003 | WO2003034027A2 Whole cell assay |
| 04/24/2003 | WO2003033717A1 Processes for producing isomaltose and isomaltitol and use thereof |
| 04/24/2003 | WO2003033713A2 Production of oil with higher erucic acid content |
| 04/24/2003 | WO2003033710A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 04/24/2003 | WO2003033709A2 Regulation of human serine/threonine protein kinase |
| 04/24/2003 | WO2003033708A2 Regulation of human serine/threonine protein kinase |
| 04/24/2003 | WO2003033707A1 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same |
| 04/24/2003 | WO2003033704A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/24/2003 | WO2003033701A1 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
| 04/24/2003 | WO2003033690A1 Protease obtained from vibrio metschnikovii variants and detergent compositions comprising the above protease |
| 04/24/2003 | WO2003033689A1 Cloning and recombinant expression of mammalian secreted group iif phopholipase a2 |
| 04/24/2003 | WO2003033688A1 Regulation of human receptor tyrosine phosphatase |
| 04/24/2003 | WO2003033680A2 Kinases and phosphatases |
| 04/24/2003 | WO2003033672A2 Nr3b nmda receptor subunit compositions and related methods |
| 04/24/2003 | WO2003033667A2 Use of mx gtpases in the prognosis and treatment of cancer |
| 04/24/2003 | WO2003033660A2 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 04/24/2003 | WO2003033650A2 Recombinant renilla reniformis system for bioluminescence resonance energy transfer |
| 04/24/2003 | WO2003033647A2 THERMOSTABLE UvrA, UvrB, AND UvrC POLYPEPTIDES AND METHODS OF USE |
| 04/24/2003 | WO2003033646A2 Compositions and methods for the modulation of viral maturation |
| 04/24/2003 | WO2003033643A2 Three dimensional crystal structure of human sorbitol dehydrogenase and uses thereof |
| 04/24/2003 | WO2003033540A2 Starch |
| 04/24/2003 | WO2003033018A1 Method for preparing purified matrix metalloproteinase |
| 04/24/2003 | WO2003032921A2 Treatment of neurodegenerative diseases and cancer of the brain |
| 04/24/2003 | WO2003032814A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | WO2003032713A2 COFFEE PLANT WITH REDUCED α-D-GALACTOSIDASE ACTIVITY |
| 04/24/2003 | WO2003014374A3 CONUS η-CARBOXYLASE |
| 04/24/2003 | WO2003006987A9 Methods and compositions for determining enzymatic activity and specificity of methyltransferases |
| 04/24/2003 | WO2003006643A3 A p387l variant in protein tyrosine phosphatase-1b is associated with type 2 diabetes and impaired serine phosphorylation of ptp-1b in vitro |
| 04/24/2003 | WO2003004612A3 Inhibitor of t cell activation |
| 04/24/2003 | WO2002102316A3 Histone deacetylase and methods of use thereof |
| 04/24/2003 | WO2002095016A3 Champ - a cardiac helicase-like factor |
| 04/24/2003 | WO2002088343A3 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT) |
| 04/24/2003 | WO2002085094A3 Transgenic mice containing acylphosphatase gene disruptions |
| 04/24/2003 | WO2002079460A3 Crystals of ketopantoate hydroxymethyl transferase |
| 04/24/2003 | WO2002079420A3 Adam-like protease disruptions, compositions and methods related thereto |
| 04/24/2003 | WO2002079412A3 Transgenic mice containing usp3-like deubiquitinating enzyme gene disruptions |
| 04/24/2003 | WO2002077187A3 Proteins producing an altered immunogenic response and methods of making and using the same |
| 04/24/2003 | WO2002072624A3 Assays, methods and means for targeting streptococcal inhibitor of complement (sic) |
| 04/24/2003 | WO2002066626A3 Regulation of human mut/nudix nucleoside triphosphate pyrophosphohydrolase |
| 04/24/2003 | WO2002066507A3 Histidine phosphatase interacting protein of 120 kd |
| 04/24/2003 | WO2002057432A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | WO2002056900A3 Use of slpi for treating chronic inflammatory intestinal diseases |
| 04/24/2003 | WO2002055710A3 Regulation of human purple acid phosphatase |
| 04/24/2003 | WO2002049576A9 Fab i and inhibition of apicomplexan parasites |
| 04/24/2003 | WO2002048344A3 Gene therapy for prostate cancer: sensibilization of cells to dn a damaging drugs and radiation |
| 04/24/2003 | WO2002048332A9 Recombinant phytases and uses thereof |
| 04/24/2003 | WO2002047710A3 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002045500A3 Transgenic mice containing ptp36 tyrosine phosphatase disruptions |
| 04/24/2003 | WO2002043741A3 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 04/24/2003 | WO2002038746A9 Novel thermostable alkaliphilic xylanase |
| 04/24/2003 | WO2002038171A3 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 04/24/2003 | WO2002034902A3 Reversibly soluble enzyme-polymer conjugates |
| 04/24/2003 | WO2002031498A3 Protecting therapeutic compositions from host-mediated inactivation |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002016615A3 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 04/24/2003 | WO2002014483A3 Human adenosine deaminase |
| 04/24/2003 | WO2002008273A3 47508, a novel human histone deacetylase family member and uses thereof |
| 04/24/2003 | WO2002006490A8 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 04/24/2003 | US20030079255 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid |
| 04/24/2003 | US20030079251 Nucleotide sequences coding polypeptide for use in enhancing digestibility of plants, improving gum extractability from plants, and altering plant propagation |
| 04/24/2003 | US20030079250 Nucleotide sequences coding polypetide for use in the modification of fatty acids in plants |
| 04/24/2003 | US20030079249 Nucleotide sequences coding polypeptide for use in altering the composition of plant oils, waxes and hydroxylated fatty acids in plants |
| 04/24/2003 | US20030079247 Nucleotide sequences codin polypeptide for use in the preparation of corn or soy animal feeds |
| 04/24/2003 | US20030079246 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |